Biomarkers of sarcopenia in very old patients with hip fracture

Autor: Carmen Sánchez‐Castellano, Sagrario Martín‐Aragón, Paloma Bermejo‐Bescós, Nieves Vaquero‐Pinto, Carmen Miret‐Corchado, Ana Merello de Miguel, Alfonso José Cruz‐Jentoft

Publikováno v: Journal of Cachexia, Sarcopenia and Muscle, Vol 11, Iss 2, Pp 478-486 (2020)

Abstract Background Hip fracture is both a cause and a consequence of sarcopenia. Older persons with sarcopenia have an increased risk of falling, and the prevalence of sarcopenia may be increased in those who suffer a hip fracture. The aim of this s

Externí odkaz: https://doaj.org/article/9ef72d22c2c54d7dbd9865fe02aa7c4a

Geriatría transversal. Un reto asistencial para el siglo xxi

Autor: Myriam Rodríguez Couso, Francisco Javier Martín-Sánchez, Carmen Sánchez Castellano, Raquel Ramírez-Martín, Javier Gómez-Pavón, Teresa Alarcón, Pilar Sáez López, Maria Pi-Figueras Valls, Carlos Rodríguez-Pascual, Rocío Menéndez Colino, José Gutiérrez Rodríguez, Jose Luis Gonzalez Guerrero, Cristina Bermejo Boixareu, José Antonio Serra Rexach, Javier Martinez Peromingo, Francisco José Tarazona-Santabalbina, A. Vilches-Moraga, Francesc Formiga, Nicolás Martínez-Velilla, Ana Isabel Hormigo Sánchez, María T. Vidán, Juan Ignacio González-Montalvo

Publikováno v: Revista Española de Geriatría y Gerontología. 55:84-97

Resumen Cada vez es mayor el numero de pacientes de edad avanzada que esta siendo tratado por especialidades diferentes a la geriatria, las cuales, por las caracteristicas de sus tratamientos, necesitan conocer el pronostico que tiene su indicacion e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5f12eea1ff0785c1a10fca150b3d40ed
https://doi.org/10.1016/j.regg.2019.10.011

Populations and outcome measures used in ongoing research in sarcopenia

Autor: Carmen Sánchez Castellano, Lilia Patricia Bustamante Montes, Gloria Gabriela Peña Ordóñez, Alfonso J. Cruz-Jentoft, Ninfa Ramírez Durán

Publikováno v: Aging clinical and experimental research. 29(4)

Sarcopenia research may be hampered by the heterogeneity of populations and outcome measures used in clinical studies. The aim of this study was to describe the inclusion/exclusion criteria and outcome measures used in ongoing research in sarcopenia.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af40552591bd12859b1d0d38cc069eea
https://pubmed.ncbi.nlm.nih.gov/27481122

The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey

Autor: Alberto Lleó, Shima Mehrabian, Alexandre de Mendonça, Brian A. Lawlor, Merja Hallikainen, Florence Pasquier, Marcel G. M. Olde Rikkert, Pablo Martinez-Lage, Henrike Wolf, Giovanni B. Frisoni, Lucrezia Hausner, Andreas U. Monsch, Mira Didic, Patrick G. Kehoe, Eduardo Aguera, Roy W. Jones, David Wilkinson, Pieter Jelle Visser, Görsev Yener, Roger Bullock, Patrizia Mecocci, Frank Jessen, Agneta Nordberg, Marie Sarazin, Jean-François Dartigues, Dina Zekry, Hermann Josef Gertz, Maria Eriksdotter, Åsa K. Wallin, Lutz Frölich, Latchezar Traykov, Eric Salmon, Carmen Sánchez-Castellano, Martina Bocchetta, Roberto Bernabei, Jean Marc Orgogozo, Gordon K. Wilcock, Samantha Galluzzi, Oliver Peters, Mathieu Ceccaldi, Steen G. Hasselbalch, Olivier Felician, Isabel Santana, Alexander Kurz, Isabell Heuser, Flavio Nobili, Magda Tsolaki

Publikováno v: Alzheimer's & Dementia, 11(2), 195-206. Elsevier Science
Alzheimer's and Dementia, Vol. 11, No 2 (2015) pp. 195-206e1
Alzheimers & Dementia, 11(2), 195-206. Elsevier
Alzheimers & Dementia
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Alzheimer's & Dementia, 11, 2, pp. 195-206.e1
Alzheimer's and dementia 11(2), 195-206.e1 (2015). doi:10.1016/j.jalz.2014.06.006
Alzheimer's & Dementia, 11, 195-206.e1
Bocchetta, M, Galluzzi, S, Kehoe, P G, Aguera, E, Bernabei, R, Bullock, R, Ceccaldi, M, Dartigues, J F, de Mendonca, A, Didic, M, Eriksdotter, M, Felician, O, Frolich, L, Gertz, H J, Hallikainen, M, Hasselbalch, S G, Hausner, L, Heuser, I, Jessen, F, Jones, R W, Kurz, A, Lawlor, B, Lleo, A, Martinez-Lage, P, Mecocci, P, Mehrabian, S, Monsch, A, Nobili, F, Nordberg, A, Rikkert, M O, Orgogozo, J M, Pasquier, F, Peters, O, Salmon, E, Sanchez-Castellano, C, Santana, I, Sarazin, M, Traykov, L, Tsolaki, M, Visser, P J, Wallin, A K, Wilcock, G, Wilkinson, D, Wolf, H, Yener, G, Zekry, D & Frisoni, G B 2015, ' The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey ', Alzheimers & Dementia, vol. 11, no. 2, pp. 195-206 . https://doi.org/10.1016/j.jalz.2014.06.006
Alzheimer's & Dementia

We investigated the use of Alzheimer's disease (AD) biomarkers in European Alzheimer's Disease Consortium centers and assessed their perceived usefulness for the etiologic diagnosis of mild cognitive impairment (MCI). We surveyed availability, freque

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ff782b833d353e1ac30f82e3ca992f2
https://cris.maastrichtuniversity.nl/en/publications/caa620c7-5f16-44ac-b7d7-f371098479c1

[Inappropriate prescription in older patients: the STOPP/START criteria]

Autor: Eva, Delgado Silveira, María, Muñoz García, Beatriz, Montero Errasquin, Carmen, Sánchez Castellano, Paul F, Gallagher, Alfonso J, Cruz-Jentoft

Publikováno v: Revista espanola de geriatria y gerontologia. 44(5)

Older people are a heterogeneous group of patients, often with multiple comorbidities for which they are prescribed a large number of drugs, leading to an increased risk of adverse drug reactions (ADR) and drug interactions. This risk is compounded b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::45b54497e9232370bc6c0ea0ccee51f8
https://pubmed.ncbi.nlm.nih.gov/21497952